TABLE 2

LC-DAD-IT-TOF-MS analysis of SSa and its observed metabolites in rat biosamples

No.TRUVPositive MS1Negative MS1Positive MSnNegative MSnIdentity
minnm
M039.9<190437.3402a, 455.3534, 583.3982, 601.4083,745.4511, 763.4635,803.4572, 819.4267779.4593, 815.4310, 825.4654a, 842.4867, 893.4467[763.4635] → 745.4532, 601.4123, 583.3985, 455.3514, 437.3403a, 419.3329[825.4654] → [779.4566a]→ [617.4067a] → 541.3513, 471.3464a, 439.3207SSab
[455.3534] → 437.3398, 425.3399, 419.3295, 407.3296, 401.3224, 389.3199, 299.2361, 285.2213, 283.2049, 267.2123, 265.1946, 253.1961, 251.1805, 241.1945, 239.1811, 233.1897, 231.1755, 223.1689, 215.1789, 213.1648, 205.1584, 201.1634, 187.1484a
M1322.9<190821.4632797.4706[797.4706] → [635.4135a] → 559.3655, 471.3479a, 439.3214HOSSc
843.4772a
M1415.2<190819.4527795.4561[795.4561] → [633.3976a] → 557.3457, 487.3436a, 455.3172Monooxidation of SSa
841.4623a
M1523.3<190819.4512795.4553[795.4553] → [633.3995a] → 487.3436aMonooxidation of SSa
841.4609a
M145.5<190437.3425a617.4076[455.3541] → 285.2224, 267.2106, 223.1687, 205.1587, 187.1478a[617.4076a] → 541.3523, 471.3485a, 439.3222PSGfc
455.3541, 601.4077663.4124a
M1616.5<190657.3997633.4018[633.4018] → 557.3489, 487.3447a, 455.3178Monooxidation of PSGf
679.4031a
M1724.5<190657.3968633.4029[633.4029] → 487.3440a, 455.3144Monooxidation of PSGf
679.4047a
M248.3<190437.3411a, 455.3527517.3513a[455.3527] → 285.2210, 267.2118, 223.1703, 205.1597, 187.1497aSGfc
M352.3<190435.3271a[453.3378] → 423.3273a, 393.3140, 285.2207, 267.2109, 233.1896, 221.1550, 215.1792, 203.1428, 175.1479Δ1-SGf
453.3378, 493.3279
M453.7<190435.3254a, 453.3372[453.3372] → 285.2217, 267.2114, 221.1536, 203.1443a, 185.13353-keto-SGf
M518.6<190453.3369a, 471.3457533.3499a[471.3457] → 249.1861, 231.1739, 223.1697, 213.1651, 205.1601, 187.1489aHydroxylation of SGf
M626.0<190453.3361a, 471.3469533.3467a[471.3469] → 453.3387aHydroxylation of SGf
[453.3361] → 229.1584, 223.1693, 211.1477, 205.1591, 187.1487a
M718.4<190467.3153a, 485.3250501.3234a[485.3250] → 455.3161, 263.1656, 245.1533, 231.1374, 223.1692, 205.1594, 199.1493, 187.1482a[501.3234] → 453.2987a, 437.3038SGf-27-oic acid
M842.2<190467.3167a, 485.3273501.3238a[485.3273] → 253.1451, 235.1340, 233.1907, 217.1224, 215.1805, 171.1169a[501.3238] → 453.2991a, 437.3044Carboxylation and hydroxylation of SGf
M927.0<190467.3158a, 485.3259501.3217a[485.3259] → 467.3140a[501.3217] → 453.3016a, 437.3069Unidentified
[467.3158] → 449.3050a, 431.2941
M1014.7<190483.3098a, 501.3199517.3171a[501.3199] → 253.1447, 249.1867, 235.1345, 231.1743, 217.1235, 213.1635, 171.1167a[517.3171] → 469.2965a, 453.3023Carboxylation and hydroxylation of SGf
M1119.6<190483.3104a, 501.3204517.3152a[501.3199] → 483.3127a[517.3152] → 469.2932a, 453.2989Unidentified
[483.3104] → 465.3021a
M1230.2<190483.3123a, 501.3207517.3184a[501.3207] → 483.3087a[517.3184] → 469.2936a, 453.2991Unidentified
[483.3123] → 465.2983a
  • HOSS, hydroxysaikosaponin; LC-DAD-IT-TOF-MS, liquid chromatography–diode array detector coupled with hybrid ion trap–time-of-flight mass spectrometry; PSGf, prosaikogenin f; SGf, saikogenin f; SSa, saikosaponin a.

  • a Of 100% relative signal intensity.

  • b With standard.

  • c With data in reference.